Modalities
Written by Animascope
Animascope utilizes a wide set of non-invasive technologies. Our multimodality approach allows optimization of each project with high flexibility. Most importantly, multimodality imaging allows us to collect, combine and compare multiple readouts within the same anatomical structure and experimental context. Pilot studies and full trials can be completed in a time-frame of days. |
 | MRI provides anatomical, functional and metabolic images with or without the use of specific contrast media. It is particularly suited for soft tissues, especially brain and heart. Routinely, spatial resolution varies around 100 µm in 3D. |
 | Using fluorescent and bioluminescent probes, in vivo whole-body imaging provides images related to specific biochemical pathways. It is also well suited for biodistribution analysis, cell trafficking and functional genomics studies. |
 | US provides 2D anatomical information. Combined with Doppler analysis, it allows evaluation of functional parameters, particularly in the cardiovascular and muscular fields. The spatial resolution ranges from 30 to 100 µm. |
 | CT is well-suited for in vivo 3D analysis of bone tissue at a high level of spatial resolution (10 µm). Using specific contrast media, it can be used for anatomical, and, in some conditions, functional analysis of soft tissues. CT provides 3D anatomical images with spatial resolution ranging from 10 to 100 µm. |
 | PET is a nuclear medicine imaging technique which produces a three-dimensional image or picture of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Images of tracer concentration in 3-dimensional space within the body are then reconstructed by computer analysis. |
- MAGNETIC RESONANCE IMAGING (MRI)
- OPTICAL IMAGING
- ULTRASOUND IMAGING (US)
- X-RAY COMPUTED TOMOGRAPHY (CT)
- POSITRON EMISSION TOMOGRAPHY (PET)
Site Search
